BioLineRx Ltd.
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$0 N/A	$0 0%	$4.8M 0%	Avg: $23.98M Low: $22.56M High: $25.4M avg. 399.58%	Avg: $36.11M Low: $32.18M High: $40.05M avg. 50.61%	Avg: $54.82M Low: $48.84M High: $60.79M avg. 51.78%
Net Income % change YoY	$-28.14M N/A	$-18.87M 32.94%	$-60.61M -221.18%	Avg: $-14.45M Low: $-26.38M High: $-1.88M avg. 76.15%	Avg: $-1.28M Low: $-1.46M High: $-1.10M avg. 91.11%	Avg: $-1.92M Low: $-2.19M High: $-1.65M avg. -50.00%
EBITDA % change YoY	$-23.43M N/A	$-22.13M 5.51%	$-57.06M -157.73%	Avg: $14.38M Low: $13.53M High: $15.24M avg. 125.21%	Avg: $21.67M Low: $19.30M High: $24.03M avg. 50.61%	Avg: $32.89M Low: $29.30M High: $36.47M avg. 51.78%
EPS % change YoY	-$0.64 N/A	-$0.37 42.18%	-$0.94 -154.05%	Avg: -$0.23 Low: -$0.41 High: -$0.03 avg. 76.06%	Avg: -$0.02 Low: -$0.02 High: -$0.02 avg. 91.11%	Avg: -$0.03 Low: -$0.03 High: -$0.03 avg. -49.99%
Operating Expenses % change YoY	$24.77M N/A	$29.15M 17.67%	$50.80M 74.23%	Avg: $50.38M Low: $47.40M High: $53.37M avg. -0.81%	Avg: $75.89M Low: $67.61M High: $84.16M avg. 50.61%	Avg: $115.19M Low: $102.63M High: $127.74M avg. 51.78%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 39.09% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -26.38M, average is -14.45M and high is -1.88M.

Wall Street analysts forecast annual average revenue growth of 167.32% in 2025-2027.

We have gathered data from 2 analysts. Their low revenue estimate is $22.56M, average is $23.98M and high is $25.4M.

Wall Street analysts forecast annual average earnings growth of 39.05% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.41, average is -$0.23 and high is $-0.02.